2011 Group Project 4: Difference between revisions
From Embryology
No edit summary |
|||
| Line 35: | Line 35: | ||
*Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients. <ref><pubmed>19361997</pubmed></ref> | *Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients. <ref><pubmed>19361997</pubmed></ref> | ||
*Using adult neurotrophic factor-secreting stem cells. <ref><pubmed>19603590</pubmed></ref> | *Using adult neurotrophic factor-secreting stem cells. <ref><pubmed>19603590</pubmed></ref> | ||
==Current/Future Research== | ==Current/Future Research== | ||
Revision as of 12:33, 25 August 2011
| Note - This page is an undergraduate science embryology student group project 2011. |
Huntington's Disease
Introduction
History
Pathogenesis and Genetics
Diagnostic Tests
Clinical Manifestations
Treatment
There is no cure for Huntington's disease. Similar to AIDS, only the symptoms can be treated to slow down the progression of the disease.
Medications
- Movement disorders
- Psychiatric disorders
Therapies
- Psychotherapy
- Speech Therapy
- Physical Therapy
- Occupational Therapy
Quite recently, there are a couple of breakthroughs for the treatment of Huntington's.
- Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients. [1]
- Using adult neurotrophic factor-secreting stem cells. [2]
Current/Future Research
Glossary
References
2011 Projects: Turner Syndrome | DiGeorge Syndrome | Klinefelter's Syndrome | Huntington's Disease | Fragile X Syndrome | Tetralogy of Fallot | Angelman Syndrome | Friedreich's Ataxia | Williams-Beuren Syndrome | Duchenne Muscular Dystrolphy | Cleft Palate and Lip
